发明授权
US06248757B1 3-(Pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives and their use as 5-HT4 ligands 失效
3-(吡咯烷-3-基)-1,3,4-恶二唑-2(3H) - 酮衍生物及其作为5-HT 4配体的用途

  • 专利标题: 3-(Pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives and their use as 5-HT4 ligands
  • 专利标题(中): 3-(吡咯烷-3-基)-1,3,4-恶二唑-2(3H) - 酮衍生物及其作为5-HT 4配体的用途
  • 申请号: US09403779
    申请日: 1999-11-04
  • 公开(公告)号: US06248757B1
    公开(公告)日: 2001-06-19
  • 发明人: Alistair LocheadSamir JeghamJean Jeunesse
  • 申请人: Alistair LocheadSamir JeghamJean Jeunesse
  • 优先权: FR9705539 19970506
  • 主分类号: A61K31445
  • IPC分类号: A61K31445
3-(Pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives and their use as 5-HT4 ligands
摘要:
Compounds corresponding to the general formula (I) in which R1 represents hydrogen or an alkyl or cycloalkylmethyl group, X1 represents hydrogen or a halogen or an alkoxy group, or alternatively OR1 and X1 together represent a group of formula —OCH2O—, —O(CH2)2—, —O(CH2)3—, —O(CH2)2O— or —O(CH2)3O—, X2 represents hydrogen, an amino group or a group of general formula —NHCO2R in which R represents an alkyl or phenylalkyl group, X3 represents hydrogen or a halogen, and R2 represents hydrogen or an alkyl, phenylalkyl or [(4-dimethylamino)piperid-1-ylcarbonyl]alkyl group. Therapeutic application.
信息查询
0/0